With increasing numbers of gastric bypass patients and Crohns resections, this deficiency could be significantly higher
Its worth noting that GLP-1 medications have already been used off-label for MASH for years, guided by medical guidelines and expert opinion
Similarly, tirzepatide, a dual GLP-1/GIP receptor agonist, demonstrated impressive results in the SYNERGY-NASH trial, with a high percentage (74%) of participants achieving an absence of NASH and no worsening of fibrosis
[29] In a 2004 interview with Fortune , Schwarzenegger said he suffered what "would now be called child abuse" at the hands of his father: "My hair was pulled
The Medicare GLP-1 Bridge is focused on the obesity indication, but the downstream benefits to the patients who take these drugs may extend across multiple organ systems potentially reducing long-term Medicare costs for cardiovascular, renal, and metabolic disease management